Fishbane, Steven
Ford, Martin
Fukagawa, Masafumi http://orcid.org/0000-0002-7832-2339
McCafferty, Kieran http://orcid.org/0000-0002-0762-2270
Rastogi, Anjay
Spinowitz, Bruce
Staroselskiy, Konstantin
Vishnevskiy, Konstantin
Lisovskaja, Vera
Al-Shurbaji, Ayman
Guzman, Nicolas
Bhandari, Sunil http://orcid.org/0000-0002-0996-9622
Article History
Received: 23 March 2021
Accepted: 14 September 2021
First Online: 8 February 2022
Declarations
:
: The DIALIZE study was performed in accordance with the Declaration of Helsinki, the International Council for Harmonisation, and Good Clinical Practice. The informed consent form, protocol, and amendments were approved by an independent ethics committee or institutional review board for each center before study initiation. All participants provided written informed consent.
: Not applicable.
: SF received research support and consulting fees from AstraZeneca. MFord received travel support from Amgen and AstraZeneca, and is an advisory board member for AstraZeneca. MFukagawa received consulting fees and lectures fees from AstraZeneca Japan. KM is an academic grant holder and advisory board member for AstraZeneca. AR received research or travel support from and/or is a speaker, consultant, or advisory board member for AstraZeneca, Relypsa, Fresenius Medical Care, Sanofi, Kadmon, AMAG, Otsuka, Genzyme, GSK, Omerus, Janssen, Reata Pharmaceuticals, Ironwood, and Amgen. BS received research grants, lecture fees and/or consulting fees from AstraZeneca, Akebia, Reata Pharmaceuticals, and Fresenius Medical Care. KS received research support from AstraZeneca. KV received research support from AstraZeneca. VL, AAS, and NG are employees of AstraZeneca. SB has given lectures and participated in an advisory board for AstraZeneca, has given lectures sponsored by Vifor Pharma, and has received travel support from AstraZeneca and Vifor Pharma.